Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Remarkable progress has been achieved for prophylactic and therapeutic interventions against human immunodeficiency virus type I (HIV-1) through antiretroviral therapy. However, vaccine development has remained challenging. Recent discoveries in broadly neutralizing monoclonal antibodies (bNAbs) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qian, Zhang, Linqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320319/
https://www.ncbi.nlm.nih.gov/pubmed/31858368
http://dx.doi.org/10.1007/s11684-019-0721-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320319/
https://www.ncbi.nlm.nih.gov/pubmed/31858368
http://dx.doi.org/10.1007/s11684-019-0721-9

Ejemplares similares